Fig. 2

Cell number of DN invariant Vα24JαQ T cells in BMT recipients with chronic GVHD

DN invariant Vα24JαQ T cells was assessed in four BMT recipients without chronic GVHD （left） and with chronic GVHD （right） before the onset of chronic GVHD （at 3 mo. after BMT）, at the onset of chronic GVHD （at 4 mo. after BMT）, and after successful prednisolone therapy for GVHD （at 6 mo. after BMT）.